Reviews

• Select this article
  • R J Santen

  Estrogen synthesis inhibitors for breast cancer: an introductory overview

  Endocr Relat Cancer 3 (1) 1-8, doi:10.1677/erc.0.0030001
  • Extract
  • Full Text (PDF)
• Select this article
  • M J Reed,
  • A Purohit,
  • L W L Woo,
  • and B V L Potter

  The development of steroid sulphatase inhibitors

  Endocr Relat Cancer 3 (1) 9-23, doi:10.1677/erc.0.0030009
  • Extract
  • Full Text (PDF)
• Select this article
  • S E Barrie and
  • M Jarman

  Inhibitors of cytochrome P450_17α (17α-hydroxylase/C17,20 lyase)

  Endocr Relat Cancer 3 (1) 25-39, doi:10.1677/erc.0.0030025
  • Extract
  • Full Text (PDF)
• Select this article
  • T M Penning

  17β-Hydroxysteroid dehydrogenase: inhibitors and inhibitor design

  Endocr Relat Cancer 3 (1) 41-56, doi:10.1677/erc.0.0030041
  • Extract
  • Full Text (PDF)
• Select this article
  • G J Gormley

  5α-Reductase inhibitors in prostate cancer

  Endocr Relat Cancer 3 (1) 57-63, doi:10.1677/erc.0.0030057
  • Extract
  • Full Text (PDF)
• Select this article
  • W R Miller

  Aromatase inhibitors

  Endocr Relat Cancer 3 (1) 65-79, doi:10.1677/erc.0.0030065
  • Extract
  • Full Text (PDF)